| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |